Impact of Hindmilk on Weight Gain Among Moderate to Very Preterm Infants in Zambia
Primary Purpose
Postnatal Growth Restriction
Status
Completed
Phase
Not Applicable
Locations
Zambia
Study Type
Interventional
Intervention
High-volume breastmilk
Sponsored by
About this trial
This is an interventional prevention trial for Postnatal Growth Restriction focused on measuring breastmilk, hindmilk, high-volume breastfeeding, postnatal growth restriction, preterm
Eligibility Criteria
Inclusion Criteria:
- Between 28 0/7 to 31 6/7 weeks of age or weighing between 1000-1999 grams,
- Admitted to the UTH NICU within 24 hours after birth, and
- Infants who have reached feeding volume ≥120 mL/kg/day at time of randomization
Exclusion Criteria:
- Who are deemed unstable by the neonatologist,
- With necrotizing enterocolitis or intestinal perforation
- Known gastrointestinal malformations,
- Major malformations or congenital anomalies, and
- Whose parents do not provide informed consent
Sites / Locations
- University Teaching Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Usual-volume breastfeeding (UV Group)
High-volume breastfeeding (HV Group)
Arm Description
Infants will receive cup-feeding (to standardize the volume at each feeding) per standard of care guidelines (SOC: 140-180 mL/kg/day) with volumes adjusted for weight and infant age.
Along with SOC volume provided via cup-feeding, the mother will continue to express and feed the baby hind-milk reaching 240 mL/kg/day with volumes adjusted for weight and infant age (200-240 ml/kg/day).
Outcomes
Primary Outcome Measures
Weight gain
Average change in weight between enrolment (baseline) up to 40 weeks post-menstrual age (PMA) or hospital discharge, whichever comes first.
Secondary Outcome Measures
Head circumference
Average change in head circumference (in centimetres using measuring tape) between enrolment (baseline) and 40 weeks post-menstrual age (PMA) or hospital discharge, whichever comes first.
Mid-arm circumference
Average change in mid-arm circumference (in centimetres using measuring tape) between enrolment (baseline) and 40 weeks post-menstrual age (PMA) or hospital discharge, whichever comes first.
Length
Average change in length (in centimetres using measuring tape) between enrolment (baseline) and 40 weeks post-menstrual age (PMA) or hospital discharge, whichever comes first.
Length of hospital stay
Average change in length of hospital stay between enrolment (baseline) and 40 weeks post-menstrual age (PMA) or hospital discharge, whichever comes first.
Characterise acceptability, feasibility, and feeding tolerance by breastfeeding women and their infants
To characterize the acceptability, feasibility, and feeding tolerance among HV breastfeeding women and their infants at the hospital.
Characterise feasibility of HV breastfeeding by healthcare workers (HCWs)
To characterize the feasibility of HV breastmilk by mothers to the infants (patients) by HCWs
Full Information
NCT ID
NCT05403684
First Posted
May 23, 2022
Last Updated
February 11, 2023
Sponsor
University of Alabama at Birmingham
Collaborators
Centre for Infectious Disease Research in Zambia, Chiesi Foundation
1. Study Identification
Unique Protocol Identification Number
NCT05403684
Brief Title
Impact of Hindmilk on Weight Gain Among Moderate to Very Preterm Infants in Zambia
Official Title
Impact of Hindmilk on Weight Gain Among Moderate to Very Preterm Infants in Zambia
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
June 13, 2022 (Actual)
Primary Completion Date
December 28, 2022 (Actual)
Study Completion Date
February 10, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alabama at Birmingham
Collaborators
Centre for Infectious Disease Research in Zambia, Chiesi Foundation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary hypothesis is that very preterm infants between 28 0/7 to 31 6/7 weeks with a birth weight from 1000-1999 grams allocated to the HV breastmilk group (200-240 mL/kg/day) until hospital discharge or 40 weeks' post-menstrual age (PMA), whichever comes first, will have increased growth velocity compared to those given UV breastmilk (140-180 mL/kg/day).
Detailed Description
The proposed study is a non-blinded randomized controlled trial with a 1:1 parallel allocation of infants to higher-volume feedings (200-240 ml/kg/day) or usual-volume feedings (140-180 ml/kg/day) using computer-generated random-block sequences. The study will enrol a total of 214 study participants including 190 preterm infants randomized controlled trial of HV feedings and 24 mothers of enrolled infants and healthcare workers for in-depth interviews. We will also screen mothers to study participants for postpartum depression using the Edinburgh Postnatal Depression Scale (EPDS) screening tool.
Study aims are:
Aim 1: To evaluate the impact of high volume (HV) feedings using additionally expressed milk at the end of feeding (hind-milk) vs usual volume (UV) feedings on growth velocity from birth to discharge or 40 weeks' PMA, whichever comes first, among very preterm infants.
Through a 1:1 randomization, the study will enrol 190 preterm infants weighing between 1,000g - 1,999g in both study arms and follow them until hospital discharge or 40 weeks' PMA, whichever comes first.
Aim 2: To evaluate the impact of HV vs UV breastfeeding until 40 weeks' PMA on all-cause neonatal mortality and morbidity (including sepsis, NEC, intestinal perforation, and hypoglycaemia).
All study participants (n=190) will be until 40 weeks' PMA to estimate its impact on all-cause neonatal mortality and morbidity.
Aim 3: To characterize the acceptability, feasibility, and feeding tolerance among HV breastfeeding women and their infants at the hospital and its feasibility by healthcare workers.
A total of 24 mothers and healthcare workers will be interviewed through in-depth interviews (IDIs) to better understand the acceptability of this intervention by the feeding mothers, the feeding tolerance by their newborns, and the feasibility of the same by the healthcare workers.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postnatal Growth Restriction
Keywords
breastmilk, hindmilk, high-volume breastfeeding, postnatal growth restriction, preterm
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The proposed study is a non-blinded randomized controlled trial with a 1:1 parallel allocation of infants to higher-volume feedings (200-240 ml/kg/day) or usual-volume feedings (140-180 ml/kg/day) using computer-generated random-block sequences.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
214 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Usual-volume breastfeeding (UV Group)
Arm Type
No Intervention
Arm Description
Infants will receive cup-feeding (to standardize the volume at each feeding) per standard of care guidelines (SOC: 140-180 mL/kg/day) with volumes adjusted for weight and infant age.
Arm Title
High-volume breastfeeding (HV Group)
Arm Type
Experimental
Arm Description
Along with SOC volume provided via cup-feeding, the mother will continue to express and feed the baby hind-milk reaching 240 mL/kg/day with volumes adjusted for weight and infant age (200-240 ml/kg/day).
Intervention Type
Other
Intervention Name(s)
High-volume breastmilk
Intervention Description
Preterm infants will be given high-volume breastmilk
Primary Outcome Measure Information:
Title
Weight gain
Description
Average change in weight between enrolment (baseline) up to 40 weeks post-menstrual age (PMA) or hospital discharge, whichever comes first.
Time Frame
Baseline up to 40 weeks PMA.
Secondary Outcome Measure Information:
Title
Head circumference
Description
Average change in head circumference (in centimetres using measuring tape) between enrolment (baseline) and 40 weeks post-menstrual age (PMA) or hospital discharge, whichever comes first.
Time Frame
Baseline up to 40 weeks PMA.
Title
Mid-arm circumference
Description
Average change in mid-arm circumference (in centimetres using measuring tape) between enrolment (baseline) and 40 weeks post-menstrual age (PMA) or hospital discharge, whichever comes first.
Time Frame
Baseline up to 40 weeks PMA.
Title
Length
Description
Average change in length (in centimetres using measuring tape) between enrolment (baseline) and 40 weeks post-menstrual age (PMA) or hospital discharge, whichever comes first.
Time Frame
Baseline up to 40 weeks PMA.
Title
Length of hospital stay
Description
Average change in length of hospital stay between enrolment (baseline) and 40 weeks post-menstrual age (PMA) or hospital discharge, whichever comes first.
Time Frame
Baseline up to 40 weeks PMA.
Title
Characterise acceptability, feasibility, and feeding tolerance by breastfeeding women and their infants
Description
To characterize the acceptability, feasibility, and feeding tolerance among HV breastfeeding women and their infants at the hospital.
Time Frame
Through study completion, on average 8 weeks after enrolment
Title
Characterise feasibility of HV breastfeeding by healthcare workers (HCWs)
Description
To characterize the feasibility of HV breastmilk by mothers to the infants (patients) by HCWs
Time Frame
Through study completion, on average 8 weeks after enrolment
Other Pre-specified Outcome Measures:
Title
Neonatal mortality
Description
Newborn status at 28 days after birth
Time Frame
28 days after birth
Title
Weight at 40 weeks PMA
Description
For infants discharged prior to 40 weeks PMA, their birthweight will be taken at 40 weeks PMA during study exit.
Time Frame
40 weeks PMA
Title
Postpartum Depression
Description
Maternal postpartum depression at at 6-8 weeks postnatally using Edinburgh Postnatal Depression Scale screening tool (scale ranges from 0-30, with 11+ indicative of depressive symptoms)
Time Frame
6-8 weeks postnatal
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
7 Days
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Between 28 0/7 to 31 6/7 weeks of age or weighing between 1000-1999 grams,
Admitted to the UTH NICU within 24 hours after birth, and
Infants who have reached feeding volume ≥120 mL/kg/day at time of randomization
Exclusion Criteria:
Who are deemed unstable by the neonatologist,
With necrotizing enterocolitis or intestinal perforation
Known gastrointestinal malformations,
Major malformations or congenital anomalies, and
Whose parents do not provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Waldemar Carlo, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Colm Travers, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Albert Manasyan, MD, MPH
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Teaching Hospital
City
Lusaka
ZIP/Postal Code
10101
Country
Zambia
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Study data will be shared upon a reasonable request to the study PI.
IPD Sharing Time Frame
Data will be available for sharing following publication of study findings (or during submission for publication if requested by the journal)
IPD Sharing Access Criteria
Following a reasonable request to the study PI.
Learn more about this trial
Impact of Hindmilk on Weight Gain Among Moderate to Very Preterm Infants in Zambia
We'll reach out to this number within 24 hrs